Produced by the Standing Senate Committee on Social Affairs, Science and Technology, this document examines the process to approve prescription pharmaceuticals in Canada with a particular focus on clinical trials.  The report outlines, amongst other things, twelve recommendations to improve the Nation’s clinical trial infrastructure.

Email this to someoneTweet about this on TwitterShare on FacebookShare on Google+Share on LinkedIn

File: Download Canada’s Clinical Trial Infrastructure